Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation proteinWÜEST, Thomas; MOOSMAYER, Dieter; PFIZENMAIER, Klaus et al.Journal of biotechnology. 2001, Vol 92, Num 2, pp 159-168, issn 0168-1656Article

TNF-selectokine: a novel prodrug generated for tumor targeting and site-specific activation of tumor necrosis factorWÜEST, Thomas; GERLACH, Elke; BANERJEE, Debola et al.Oncogene (Basingstoke). 2002, Vol 21, Num 27, pp 4257-4265, issn 0950-9232, 9 p.Article

Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivativeWAJANT, Harald; MOOSMAYER, Dieter; WÜEST, Thomas et al.Oncogene (Basingstoke). 2001, Vol 20, Num 30, pp 4101-4106, issn 0950-9232Article

Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomasMERSMANN, Michael; SCHMIDT, Alexej; RIPPMANN, Jörg F et al.International journal of cancer. 2001, Vol 92, Num 2, pp 240-248, issn 0020-7136Article

Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumorsMOOSMAYER, Dieter; BERNDORFF, Dietmar; DINKELBORG, Ludger M et al.Clinical cancer research. 2006, Vol 12, Num 18, pp 5587-5595, issn 1078-0432, 9 p.Article